Clinical Trial Update: Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning [Phase 4]

View source ↗

Summary

This Phase 4 trial compares brain effects of risperidone and paliperidone (Invega) using fMRI and PET imaging in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• INVEGA (PALIPERIDONE)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: University of California, Irvine | Conditions: Schizophrenia | Phase 4 | Status: UNKNOWN